3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
8
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Meningioma
7
Brain Neoplasms
6
Leukemia, Myeloid, Acute
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
3
Glioblastoma
3
Stomach Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Thyroid Carcinoma, Anaplastic
1
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pharyngeal Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Nasopharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
fludarabine phosphate
18
Cyclophosphamide
16
Peripheral Blood Stem Cell Transplantation
12
Whole-Body Irradiation
11
Busulfan
11
Tacrolimus
10
Mycophenolic Acid
10
ruxolitinib
9
fludarabine
7
Methotrexate
6
Cyclosporine
6
Radiotherapy
5
Aspirin
5
Prednisone
4
Melphalan
4
Imatinib Mesylate
4
Biopsy
4
Antilymphocyte Serum
4
peginterferon alfa-2a
3
givinostat hydrochloride
3
givinostat
3
Stem Cell Transplantation
3
Specimen Handling
3
Decitabine
3
bomedemstat
2
Thiotepa
2
Surveys and Questionnaires
2
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
2
Methylprednisolone
2
Lenalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Polycythemia Vera
×
Hydroxyurea
×
Clear all
NCT00928707
2019-10-31
PV
Italfarmaco
Phase 2
Completed
45 enrolled
10 charts